Journal of Vascular and Endovascular Therapy

Diffuse Drug-Induced Dermatitis following Sclerotherapy for Telangiectasias

Sclerotherapy is an effective treatment modality for the management of lower extremity telangiectasias. Although localized dermatologic reactions are known complications of this procedure, systemic reactions are rare. Here, we present a case of a diffuse drug eruption following sclerotherapy for the treatment of bilateral lower extremity telangiectasias. Salient clinical and physical exam findings are described. Management strategies for the treatment of drug eruptions are outlined. This is the first case report that we know of describing a diffuse drug eruption associated with sclerotherapy. It is important to recognize the possibility of diffuse drug eruptions secondary to sclerotherapy treatment so that expectant management may be initiated expeditiously in affected patients.

Author(s):

Libby MW, Caitlin WH, Deniz OA and Heller JA

Abstract | Full-Text | PDF

Share this